Sessioni Simposi
Alzheimer's disease and anti-Amyloid β immunotherapy clinical studies. A critical review (SIF-SINDEM joint symposium)
Mercoledì 28 Ottobre 2015 / 17.30-19.00
| Limits in the design and interpretation of controlled clinical trials based on anti-amyloid agents Padovani A. |
| Has the amyloid cascade a central role in Alzheimer's disease pathogenesis? Di Luca M. |
| Limits of the amyloid cascade hypothesis in the pathogenesis of Alzheimer disease, lessons from randomized controlled trials Musicco M. |
| What is the future of the anti-amyloid treatments for Alzheimer's disease - the pharmaceutical companies' opinion Dell`Agnello G. |